These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16808058)

  • 21. Targeted drug delivery systems for the intracellular delivery of macromolecular drugs.
    Koning GA; Storm G
    Drug Discov Today; 2003 Jun; 8(11):482-3. PubMed ID: 12818515
    [No Abstract]   [Full Text] [Related]  

  • 22. Multicomponent nanochains for treating cancer micrometastasis.
    Park K
    J Control Release; 2014 Jan; 173():166. PubMed ID: 24365051
    [No Abstract]   [Full Text] [Related]  

  • 23. BIOCOMPATIBLE TARGETING HYDROGELS FOR BREAST CANCER TREATMENT.
    Cassano R; Mellace S; Pellegrino M; Ricchio E; Mauro L; Andò S; Picci N; Trombino S
    Mini Rev Med Chem; 2016; 16(8):651-7. PubMed ID: 26156550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of tumor vascular architecture in drug delivery.
    Narang AS; Varia S
    Adv Drug Deliv Rev; 2011 Jul; 63(8):640-58. PubMed ID: 21514334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination drug delivery via multilamellar vesicles enables targeting of tumor cells and tumor vasculature.
    Liu Y; Kim YJ; Siriwon N; Rohrs JA; Yu Z; Wanga P
    Biotechnol Bioeng; 2018 Jun; 115(6):1403-1415. PubMed ID: 29457630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applications of Important Polysaccharides in Drug Delivery.
    Huang G; Mei X; Xiao F; Chen X; Tang Q; Peng D
    Curr Pharm Des; 2015; 21(25):3692-6. PubMed ID: 25578889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Open access to breast tumours.
    Bradbury J
    Lancet Oncol; 2006 Mar; 7(3):197. PubMed ID: 16538778
    [No Abstract]   [Full Text] [Related]  

  • 28. [Trastuzumab treatment for breast cancer].
    Yamashiro H; Toyama K; Bando H; Saji S; Toi M
    Nihon Rinsho; 2004 Jul; 62(7):1305-11. PubMed ID: 15283148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arsenic nanoparticle holds promise in blocking aggressive breast cancer.
    Printz C
    Cancer; 2010 Dec; 116(24):5567. PubMed ID: 21218458
    [No Abstract]   [Full Text] [Related]  

  • 30. Enhancing the site-specific targeting of macromolecular anticancer drug delivery systems.
    Neerman MF
    Curr Drug Targets; 2006 Feb; 7(2):229-35. PubMed ID: 16475963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second-line treatment of postmenopausal women with advanced breast carcinoma.
    Board RE; Dean EJ; Mitchell C; Wardley AM
    Expert Rev Anticancer Ther; 2006 Apr; 6(4):613-24. PubMed ID: 16613548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relay Drug Delivery for Amplifying Targeting Signal and Enhancing Anticancer Efficacy.
    Hu Q; Sun W; Qian C; Bomba HN; Xin H; Gu Z
    Adv Mater; 2017 Apr; 29(13):. PubMed ID: 28160337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls.
    Nakamura H; Fang J; Maeda H
    Expert Opin Drug Deliv; 2015 Jan; 12(1):53-64. PubMed ID: 25425260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting Brn-3b in breast cancer therapy.
    Budhram-Mahadeo VS; Latchman DS
    Expert Opin Ther Targets; 2006 Feb; 10(1):15-25. PubMed ID: 16441225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting mitochondrial function for the treatment of breast cancer.
    Deus CM; Coelho AR; Serafim TL; Oliveira PJ
    Future Med Chem; 2014 Sep; 6(13):1499-513. PubMed ID: 25365234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Target achieved.
    Montemurro F
    Expert Opin Pharmacother; 2005 Jun; 6(7):1047-8. PubMed ID: 15957960
    [No Abstract]   [Full Text] [Related]  

  • 37. TKD peptide as a ligand targeting drug delivery systems to memHsp70-positive breast cancer.
    Meng Y; Wang S; Li C; Qian M; Zheng Y; Yan X; Huang R
    Int J Pharm; 2016 Feb; 498(1-2):40-8. PubMed ID: 26680317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release.
    Hosoya H; Dobroff AS; Driessen WH; Cristini V; Brinker LM; Staquicini FI; Cardó-Vila M; D'Angelo S; Ferrara F; Proneth B; Lin YS; Dunphy DR; Dogra P; Melancon MP; Stafford RJ; Miyazono K; Gelovani JG; Kataoka K; Brinker CJ; Sidman RL; Arap W; Pasqualini R
    Proc Natl Acad Sci U S A; 2016 Feb; 113(7):1877-82. PubMed ID: 26839407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in tumor vasculature targeting using liposomal drug delivery systems.
    Abu Lila AS; Ishida T; Kiwada H
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1297-309. PubMed ID: 19780711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual stimuli-responsive multi-drug delivery system for the individually controlled release of anti-cancer drugs.
    Xiao W; Zeng X; Lin H; Han K; Jia HZ; Zhang XZ
    Chem Commun (Camb); 2015 Jan; 51(8):1475-8. PubMed ID: 25494173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.